Ignite Creation Date:
2024-05-06 @ 12:00 PM
Last Modification Date:
2024-10-26 @ 12:53 PM
Study NCT ID:
NCT03654716
Status:
COMPLETED
Last Update Posted:
2023-08-14
First Post:
2018-08-29
Brief Title:
Phase 1 Study of the Dual MDM2MDMX Inhibitor ALRN-6924 in Pediatric Cancer
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-11-01
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-07-17
Completion Date Type:
ACTUAL
First Submit Date:
2018-08-29
First Submit QC Date:
August 29 2018
Study First Post Date:
2018-08-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-10
Last Update Post Date:
2023-08-14
Last Update Post Date Type:
ACTUAL